Stuart D'Aloisio is a partner in our intellectual property and media practice
Stuart's practice covers all areas of intellectual property law, with a particular focus on intellectual property litigation and transactional work.
Stuart has a broad range of litigation experience including patent, trade mark, copyright, registered design and breach of confidence proceedings. Stuart has particular expertise advising pharmaceutical and biotechnology companies in relation to patent infringement and validity issues, patent litigation and the regulation of therapeutic goods in Australia. Stuart has acted in long-running patent litigation concerning some of the most valuable blockbuster drugs on the Pharmaceutical Benefits Scheme. Stuart's litigation experience also includes IT-related copyright and patent disputes.
On the transactional side, Stuart advises a range of clients (particularly in the mining, power and utilities, life sciences, technology, media and telecommunication sectors) in relation to the acquisition and licensing of intellectual property rights and R&D collaborations. Stuart also has experience advising on plant breeder's rights and genetically modified crops.
Stuart's international experience includes several years working in London, Hong Kong and Shanghai.
Latest thinking
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
Legal development
Seeing eye to eye: biosimilar patent case resolved
04 Dec 2025
Discover more -
Legal development
Wearing thin: The "repair defence" to patent infringement in Australia
26 Aug 2025
Discover more -
Legal development
Reasonable belief: The first successful application of the Public Interest defence in Australia
21 Aug 2025
Discover more -
Legal development
Being present: Drafting effective intellectual property assignments
18 Aug 2025
Discover more -
Legal development
I.P., or not I.P.? Data rights in the energy & resources sector
14 Jan 2025
Discover more -
Legal development
Patentee hides the "key": patents invalid for lack of best method
21 Nov 2024
Discover more -
Legal development
Routine risks: Full Court invalidates two follow-on pharmaceutical patents
25 Oct 2024
Discover more -
Legal development
Your number one asset and number one risk: IP rights and personnel in the energy & resources sector
24 Aug 2023
Discover more -
Legal development
Software beware: software development risks in the energy & resources sector
17 Jul 2023
Discover more -
Legal development
Copyright Enforcement in the Digital Age - Is it fit for purpose
25 Jan 2023
Discover more -
Legal development
The High Court does not go all in 3 3 split on patentability of feature games
26 Aug 2022
Discover more -
Legal development
Patent entitlement - the corrosive effect of failing to document the inventive process
04 Jul 2022
Discover more
Latest news, deals and awards
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.